Skip Nav Destination
Issues
1 May 2022
-
Cover Image
Cover Image
The carcinogenic effect of tobacco smoke on the hypopharynx and its combination with bile reflux has not yet been proven by direct evidence. In a study starting on page 297, Vageli and colleagues demonstrate for the first time that refluxate containing bile acids exacerbates the development and progression of hypopharyngeal cancer induced by chronic exposure of tobacco smoke component nitrosamines in vivo, via activating the NF-κB pathway. The cover image depicts the strong nuclear staining of p-NF-κB (p65 S536) of murine hypopharyngeal mucosa of C57Bl6J mice after 12 weeks of exposure to tobacco smoke carcinogens combined with bile acid, which composes an aggressive molecular phenotype. The Immunohistochemical analysis for p-NF-κB (p65 S536) and image analyses algorithm(s) were generated by Image Scope software (Leica Microsystems): red, strong positive nuclear staining; orange, intense positive cytoplasmic staining; yellow, weak cytoplasmic staining; blue, negative staining. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Commentaries
Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs
Goli Samimi; Margaret House; Kelly Benante; Lisa Bengtson; Troy Budd; Bridget Dermody; Katina DeShong; Valerie Dyer; Bruce F. Kimler; Vikrant V. Sahasrabuddhe; Suzanne Siminski; Leslie G. Ford; Eduardo Vilar; Eva Szabo
Research Articles
Family History and Risk of Bladder Cancer: An Analysis Accounting for First- and Second-degree Relatives
Evan Yi-Wen Yu; Mariana C. Stern; Xuejuan Jiang; Li Tang; Piet A. van den Brandt; Chih-Ming Lu; Margaret R. Karagas; Carlo La Vecchia; Cristina Bosetti; Jerry Polesel; Klaus Golka; Zuo-Feng Zhang; Paul Villeneuve; Maurice P. Zeegers; Anke Wesselius
Implementing Strategies at the Workplace Level to Increase Colorectal Cancer Screening Uptake in Argentina: A Controlled Interrupted Time-series Study
Ariel Esteban Bardach; Andres Pichon-Riviere; Luz Gibbons; Juan Pedro Alonso; Sacha Alexis Virgilio; María Belizán; Mariana Comolli; Lucas Angel González
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.